LT2000081A - Štampuota tabletė, duodanti prolonguotą gliklazido išsiskyrimą, vartojant ją peroraliniu būdu - Google Patents

Štampuota tabletė, duodanti prolonguotą gliklazido išsiskyrimą, vartojant ją peroraliniu būdu

Info

Publication number
LT2000081A
LT2000081A LT2000081A LT2000081A LT2000081A LT 2000081 A LT2000081 A LT 2000081A LT 2000081 A LT2000081 A LT 2000081A LT 2000081 A LT2000081 A LT 2000081A LT 2000081 A LT2000081 A LT 2000081A
Authority
LT
Lithuania
Prior art keywords
gliclazide
oral administration
controlled release
core tablet
release
Prior art date
Application number
LT2000081A
Other languages
English (en)
Other versions
LT4932B (lt
Inventor
Bruno Huet-De-Barochez
Patrick Wuthrich
Louis Martin
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Priority to LT2000081A priority Critical patent/LT4932B/lt
Publication of LT2000081A publication Critical patent/LT2000081A/lt
Publication of LT4932B publication Critical patent/LT4932B/lt

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Išradimas yra susijęs su prolonguoto gliklazido išsiskyrimo štampuota tablete, duodančia nepertraukiamą ir vienodą veikliosios medžiagos išsiskyrimą, nejautrų terpės pH pokyčiams, priėmus ją peroraliniu būdu.ą
LT2000081A 2000-08-29 2000-08-29 Štampuota tabletė, duodanti prolonguotą gliklazido išsiskyrimą, vartojant ją peroraliniu būdu LT4932B (lt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LT2000081A LT4932B (lt) 2000-08-29 2000-08-29 Štampuota tabletė, duodanti prolonguotą gliklazido išsiskyrimą, vartojant ją peroraliniu būdu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LT2000081A LT4932B (lt) 2000-08-29 2000-08-29 Štampuota tabletė, duodanti prolonguotą gliklazido išsiskyrimą, vartojant ją peroraliniu būdu

Publications (2)

Publication Number Publication Date
LT2000081A true LT2000081A (lt) 2002-03-25
LT4932B LT4932B (lt) 2002-07-25

Family

ID=19721487

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2000081A LT4932B (lt) 2000-08-29 2000-08-29 Štampuota tabletė, duodanti prolonguotą gliklazido išsiskyrimą, vartojant ją peroraliniu būdu

Country Status (1)

Country Link
LT (1) LT4932B (lt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346709A (en) 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier

Also Published As

Publication number Publication date
LT4932B (lt) 2002-07-25

Similar Documents

Publication Publication Date Title
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
LTC1345910I2 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
EP1286662A4 (en) TABLETS AND METHODS FOR MODIFIED RELEASE OF HYDROPHILIC AGENTS OR OTHER AGENTS
AU2001286940A1 (en) Drug delivering prostheses and methods of use
AU6872201A (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
EE05149B1 (et) Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis
EE05001B1 (et) Heterotsüklilised ühendid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
GB0017060D0 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
PL344564A1 (en) Matrix tablet enabling prolonged release of trimethiazidine after oral administration and method of making such tablet
ZA966163B (en) Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives.
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
HK1047548A1 (zh) 包含有米氮平和哲比隆的治療抑鬱症及其它機能紊亂症的合成藥物
LT2000081A (lt) Štampuota tabletė, duodanti prolonguotą gliklazido išsiskyrimą, vartojant ją peroraliniu būdu
IL155819A0 (en) Methods of treatment comprising administration of substance p
NO20024823L (no) Medisinske preparater inneholdende camptothecin-derivat og pH regulerende middel
AU2002220921A1 (en) Treatment of posterior capsule opacification
ZA200210361B (en) Method of administering bishosphonates.
LV12803B (en) Tablet matrix for prolonged release of gliclazide
JO2173B1 (en) A tablet block enables increased emission of glycol, further after oral administration
GB0007788D0 (en) Method to evaluate the therapeutic and toxic effects related to drug administration
GB0010124D0 (en) Administration of beneficial substances
GB0008741D0 (en) Administration of beneficial substances

Legal Events

Date Code Title Description
MK9A Expiry of a patent

Effective date: 20200829